Clinical Trial Update: Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating interleukin-12 for AIDS-related Kaposi's sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidemic Kaposi Sarcoma
• Kaposi Sarcoma

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Epidemic Kaposi's Sarcoma, Recurrent Kaposi's Sarcoma | Phase 1, Phase 2 | Status: COMPLETED